Characterization of persistent symptoms after SARS-CoV-2 infection

Post COVID 19 persistent symptoms

Authors

  • junnai carrillo
  • Vanesa Fridman
  • Daniel Stecher

DOI:

https://doi.org/10.52226/revista.v29i107.95

Keywords:

post covid, SARS-CoV-2, COVID-19, persistent symptoms

Abstract

Background: It is frequent that patients complain of persistent symptoms after an episode of COVID-19 infection, that worsened their quality of life

Aim: the aim of this study is to describe the main symptoms during a COVID-19 infection and persistent symptoms a month and three months after the episode. Our secondary objective is to describe the period between the COVID-19 episode and resuming work/ studies and exercise routine.  

Methods: this is a descriptive, observational study that included adults who underwent an episode of SARS-CoV-2 infection. Participants responded to an online survey. We include demographic and comorbidity data and symptoms during infection, and  one and three months after infection. 

Results: 308 people responded to the survey, frequent symptoms during the episode included myalgia and fever. A month after the episode, 96% complained of persistent symptoms, most frequently myalgia and fatigue. Three months after the episode 38.85% complained of  persistent symptoms , most frequently  fatigue and anosmia. Only 45.7% could resume work/ studies 10 days after the diagnosis, and 17% could resume exercise routine 10 days after the diagnosis. Conclusions: there is a high percentage of people who persisted with symptoms after a COVID-19 infection. We noticed symptoms improved over time, this finding  could be encouraged for patients who persist symptomatic after the episode.  

Downloads

Download data is not yet available.

Author Biographies

  • junnai carrillo, ,

    Médica Residente de tercer año, Enfermedades Infecciosas, División Infectología, Departamento de Medicina Interna, Hospital de Clínicas “José de San Martín”, Universidad de Buenos Aires, Argentina. Av. Córdoba 2351. Piso 3, Sala 2. CP 1120 CABA.

  • Vanesa Fridman, ,

    Médica Especialista en Enfermedades Infecciosas, Médica de Planta, División Infectología, Departamento de Medicina Interna, Hospital de Clínicas “José de San Martín”, Universidad de Buenos Aires, Argentina. Av. Córdoba 2351. Piso 3, Sala 2. CP 1120 CABA.

     

  • Daniel Stecher, ,

    Médico Especialista en Enfermedades Infecciosas, Jefe de División Infectología, Departamento de Medicina Interna, Hospital de Clínicas “José de San Martín”, Universidad de Buenos Aires, Argentina.

    Av. Córdoba 2351. Piso 3, Sala 2. CP 1120 CABA.

ASEI 107 CARRILLO

Downloads

Published

2021-11-26

Issue

Section

Original article

How to Cite

Characterization of persistent symptoms after SARS-CoV-2 infection: Post COVID 19 persistent symptoms. (2021). Actualizaciones En Sida E Infectología, 29(107). https://doi.org/10.52226/revista.v29i107.95